ArticleThe New England journal of medicine2015
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
Stephen M Ansell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,942 papers cite itlatest 60 shown
this paperpooled ittrialcites it